1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.
More Information Supplier Page
1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.
More Information Supplier Page
1NM-PP1 is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors with IC50 of 28 μM for vSrc and 4.2 nM for v-Src-as1 I338G.
More Information Supplier Page 
Isavuconazole is a broad-spectrum triazole antifungal agent used to treat invasive aspergillosis and invasive mucormycosis.
More Information Supplier Page
Isavuconazole is a broad-spectrum triazole antifungal agent used to treat invasive aspergillosis and invasive mucormycosis.
More Information Supplier Page
Isavuconazole is a broad-spectrum triazole antifungal agent used to treat invasive aspergillosis and invasive mucormycosis.
More Information Supplier Page 
Tasquinimod allosterically inhibits HDAC4 signalling with antiangiogenic and antineoplastic activities. It is a quinoline-3-carboxamide linomide analogue.
More Information Supplier Page
Tasquinimod allosterically inhibits HDAC4 signalling with antiangiogenic and antineoplastic activities. It is a quinoline-3-carboxamide linomide analogue.
More Information Supplier Page Tasquinimod allosterically inhibits HDAC4 signalling with antiangiogenic and antineoplastic activities. It is a quinoline-3-carboxamide linomide analogue.
More Information Supplier Page 
Tasquinimod allosterically inhibits HDAC4 signalling with antiangiogenic and antineoplastic activities. It is a quinoline-3-carboxamide linomide analogue.
More Information Supplier Page
